title: Bilateral uterine artery chemoembolization with methotrexate for cesarean scar pregnancy.
abstract: OBJECTIVE
  The objective of the study was to assess the efficacy of uterine arteries embolization (UAE) for the treatment of cesarean scar pregnancies (CSP).
  
  
  METHODS
  Forty-six women with CSP were identified between March 2008 and March 2010. All of the patients underwent UAE combined with local methotrexate.
  
  
  RESULTS
  Forty-five patients were successfully treated. One patient had an emergency hysterectomy after 20 days because of massive vaginal hemorrhage. The mean time until normalization of serum β-human chorionic gonadotrophin was 37.7 days, and the mean time until CSP mass disappearance was 33.3 days. The mean hospitalization time was 10.5 days. The complications were mainly fever and pain, which were alleviated with symptomatic treatment. All 45 patients had recovered their normal menstruation at follow-up.
  
  
  CONCLUSIONS
  Bilateral uterine artery chemoembolization with methotrexate appears to be a safe and effective treatment for CSP and causes less morbidity than current approaches.
authors.affiliation: Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, People's Republic of China.
authors.forename: Licong
authors.initials: L
authors.lastname: Shen
authors.forename: Aixiang
authors.initials: A
authors.lastname: Tan
authors.forename: Huili
authors.initials: H
authors.lastname: Zhu
authors.forename: Chun
authors.initials: C
authors.lastname: Guo
authors.forename: Dong
authors.initials: D
authors.lastname: Liu
authors.forename: Wei
authors.initials: W
authors.lastname: Huang
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000328:Adult; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D002921:Cicatrix / Q000188:drug therapy*; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D007044:Hysterectomy; D007902:Length of Stay; D008727:Methotrexate / Q000627:therapeutic use*; D010146:Pain / Q000209:etiology; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000601:surgery; D012189:Retrospective Studies; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014463:Ultrasonography; D055357:Uterine Artery Embolization / Q000379:methods*; D014592:Uterine Hemorrhage / Q000209:etiology / Q000601:surgery; D016064:Vaginal Birth after Cesarean; D055815:Young Adult
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D018997:Chorionic Gonadotropin, beta Subunit, Human; D008727:Methotrexate